Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:58:26 EDT Wed 02 Jul 2025
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:IPHA
- INNATE PHARMA SPON ADS EACH REP 1 ORD SHS -
Website unknown - click to update
23:58:26 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
IPHA
- Q
1.2
1.81
·
2.88
0.6
1.82
-0.025
-1.4
5.4
9
23
1.85
1.8989
1.82
3.5107 1.29
15:58:22
Jun 17
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 23
More trades...
Time ET
Ex
Price
Change
Volume
15:58:22
Q
1.8468
0.0018
27
15:56:02
Q
1.82
-0.025
2
15:46:30
Q
1.82
-0.025
1
15:28:34
Q
1.82
-0.025
20
15:22:04
Q
1.82
-0.025
26
15:22:04
Q
1.82
-0.025
153
15:09:45
Q
1.82
-0.025
40
15:09:44
Q
1.83
-0.015
62
11:36:41
Q
1.85
0.005
1
11:23:59
Q
1.85
0.005
786
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2025-06-17 01:00
U:IPHA
News Release
200
Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences
2025-06-13 01:00
U:IPHA
News Release
200
Innate Pharma Highlights Preclinical Antitumor Activity of IPH6501 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma at the 2025 European Hematology Association (EHA) Congress
2025-05-27 01:00
U:IPHA
News Release
200
Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences
2025-05-23 01:00
U:IPHA
News Release
200
Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides
2025-05-23 01:00
U:IPHA
News Release
200
Outcome of Innate Pharma's 2025 Annual General Meeting
2025-05-19 01:00
U:IPHA
News Release
200
Innate Pharma Highlights Abstracts Selected for ASCO 2025 Annual Meeting
2025-05-15 01:00
U:IPHA
News Release
200
Innate Pharma Highlights ANKET(TM) Abstracts Selected for the EHA 2025 Congress
2025-05-13 01:00
U:IPHA
News Release
200
Innate Pharma Reports First Quarter 2025 Business Update and Financial Results
2025-05-12 01:00
U:IPHA
News Release
200
Number of Shares and Voting Rights of Innate Pharma as of May 5, 2025
2025-05-06 01:00
U:IPHA
News Release
200
Innate Pharma announces conference call and webcast for Q1 2025 business update
2025-04-30 11:30
U:IPHA
News Release
200
Innate Pharma Files Its 2024 Universal Registration Document (Document d'enregistrement universel) and 2024 Annual Report on Form 20-F
2025-04-29 15:00
U:IPHA
News Release
200
Innate Pharma Highlights Preclinical Anti-Tumor Efficacy Data of Its Antibody Drug Conjugate IPH4502 at the AACR 2025 Annual Meeting
2025-04-28 01:00
U:IPHA
News Release
200
Number of Shares and Voting Rights of Innate Pharma as of April 25, 2025
2025-04-24 01:35
U:IPHA
News Release
200
Innate Pharma Announces euros15M Investment by Sanofi
2025-04-23 01:00
U:IPHA
News Release
200
Innate Pharma Regains Its Rights on CD123 Targeting ANKET(TM) and Announces Sanofi's Intention to Make a Strategic Investment in the Company
2025-04-16 01:00
U:IPHA
News Release
200
Innate Pharma Proposes to Its Shareholders to Transform Its Corporate Governance Structure Into a Board of Directors and to Change Its Composition
2025-04-16 01:00
U:IPHA
News Release
200
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025
2025-04-03 01:00
U:IPHA
News Release
200
Innate Pharma to Participate in the 2025 Stifel Virtual Targeted Oncology Forum
2025-03-27 02:00
U:IPHA
News Release
200
Innate Pharma Reports Full Year 2024 Financial Results and Business Update
2025-03-26 02:00
U:IPHA
News Release
200
Innate Pharma Highlights Antibody Drug Conjugate IPH4502 Abstract Selected for the AACR 2025 Annual Meeting